Alexis M. Bachmann

Alexis M. Bachmann

Auto-generated profile, based on publicly available information

Alexis M. Bachmann

Laboratory of Integrative Systems Physiology, École polytechnique fédérale de Lausanne 1 , Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
GBGiorgia Benegiamo
Giorgia Benegiamo
GAGiacomo V.G. von Alvensleben
Giacomo V.G. von Alvensleben
SRSandra Rodríguez-López
Sandra Rodríguez-López
LGLudger J.E. Goeminne
Ludger J.E. Goeminne
ABAlexis M. Bachmann
Alexis M. Bachmann
JAJohan Auwerx
Johan Auwerx
Non-alcoholic steatohepatitis (NASH) is a global health concern without treatment. The challenge in finding effective therapies is due to the lack of good mouse models and the complexity of the disease, characterized by gene–environment interactions. We tested the susceptibility of seven mouse strains to develop NASH. The severity of the clinical phenotypes observed varied widely across strains. PWK/PhJ mice were the most prone to develop hepatic inflammation and the only strain to progress to NASH with extensive fibrosis, while CAST/EiJ mice were completely resistant. Levels of mitochondrial transcripts and proteins as well as mitochondrial function were robustly reduced specifically in the liver of PWK/PhJ mice, suggesting a central role of mitochondrial dysfunction in NASH progression. Importantly, the NASH gene expression profile of PWK/PhJ mice had the highest overlap with the human NASH signature. Our study exposes the limitations of using a single mouse genetic background in metabolic studies and describes a novel NASH mouse model with features of the human NASH.